Lantern Pharma Reaffirms Panna Sharma’s Ongoing Role as President and CEO; Warns Investors of Misleading Third-Party Report Lantern Pharma Inc., an AI-driven oncology company focused on transforming cancer drug development…
Ono Pharma Files for Approval of Ripretinib (DCC-2618) to Treat Advanced Gastrointestinal Stromal Tumors in Japan Ono Pharmaceutical Co., Ltd. has announced the submission of a regulatory application in Japan…
Neurocrine Biosciences Unveils First Expert Consensus Guidelines for Managing Tardive Dyskinesia in Long-Term Care Settings Neurocrine Biosciences, Inc. today announced the presentation of the first expert consensus recommendations focused on screening,…
Allergan Aesthetics Introduces Next-Generation Hyaluronic Acid Injectables with JUVÉDERM at AMWC Monaco Allergan Aesthetics, an AbbVie company, a global leader in medical aesthetics treatments and manufacturers of the market-leading JUVÉDERM® Collection…
Novo Nordisk Secures U.S. Approval for Awiqli, the First Once-Weekly Basal Insulin for Adults with Type 2 Diabetes Novo Nordisk today announced that the US Food and Drug Administration (FDA)…
Abcuro Highlights Phase 2/3 MUSCLE Study Results of Ulviprubart in Inclusion Body Myositis at GCOM 2026 Abcuro, Inc. has announced new clinical data from its Phase 2/3 MUSCLE study evaluating…
Drug Farm Secures U.S. FDA Orphan Drug Designation for DF-003 in Treating ROSAH Syndrome Drug Farm has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug…
Nordic Cold Chain Solutions Unveils Innovation Lab Focused on GLP-1 and Small-Format Packaging Solutions Nordic Cold Chain Solutions has announced the launch of its GLP-1 & Small-Format Packaging Innovation Lab,…
Invivoscribe Expands IVDR Portfolio with Certification of IdentiClone Dx IGH Assay Invivoscribe, a globally recognized leader in precision diagnostics and measurable residual disease (MRD) testing, has announced a major regulatory…
Aledade Partners Demonstrate Superior Hypertension Control, Surpassing Large Health Systems in New Case Study Aledade, a physician-led organization recognized as a national leader in advancing value-based care, has released the…
Alpha Cognition Inc. Announces Fiscal 2025 Financial Results and Operational Progress Update Alpha Cognition Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurodegenerative disorders, has reported its…
Agenus to Host March 2026 Stakeholder Webcast Highlighting Progress of BOT + BAL Immunotherapy and Expanding Patient Access Across Multiple Tumor Types Agenus Inc., a biotechnology company focused on advancing…